Dr. Grainger S. Lanneau
Claim this profileVidant Medical Center
Studies Ovarian Cancer
Studies Ovarian Tumors
3 reported clinical trials
6 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage II
Stage III
2Ovarian Tumors
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Grainger S. Lanneau is currently running
ADP-A2M4CD8 + Nivolumab
for Ovarian Cancer
This trial tests a treatment using modified immune cells alone or with an immune-boosting drug in patients with recurrent ovarian cancer who have a specific genetic marker. The treatment aims to help the immune system better identify and destroy cancer cells.
Recruiting1 award Phase 221 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Grainger S. Lanneau
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Grainger S. Lanneau has experience with
- ADP-A2M4CD8
- Nivolumab
- Letrozole
- Paclitaxel, Carboplatin
- Olaparib
- Temozolomide
Breakdown of trials Grainger S. Lanneau has run
Ovarian Cancer
Ovarian Tumors
Adenocarcinoma
Fallopian Tube Serous Adenocarcinoma
Ovarian Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Grainger S. Lanneau specialize in?
Grainger S. Lanneau focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage II.
Is Grainger S. Lanneau currently recruiting for clinical trials?
Yes, Grainger S. Lanneau is currently recruiting for 2 clinical trials in Greenville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Grainger S. Lanneau has studied deeply?
Yes, Grainger S. Lanneau has studied treatments such as ADP-A2M4CD8, Nivolumab, Letrozole.
What is the best way to schedule an appointment with Grainger S. Lanneau?
Apply for one of the trials that Grainger S. Lanneau is conducting.
What is the office address of Grainger S. Lanneau?
The office of Grainger S. Lanneau is located at: Vidant Medical Center, Greenville, North Carolina 27834 United States. This is the address for their practice at the Vidant Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.